Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom
Authors
Keywords
Conjoint, Discrete-choice experiment, Dosing frequency, Exenatide, Glucagon-like peptide-1 receptor agonists, Liraglutide, Treatment preference, Type 2 diabetes mellitus
Journal
Diabetes Therapy
Volume 8, Issue 2, Pages 335-353
Publisher
Springer Nature
Online
2017-02-24
DOI
10.1007/s13300-017-0237-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes
- (2016) James J. Chamberlain et al. ANNALS OF INTERNAL MEDICINE
- Medication Adherence Affects Risk of New Diabetes Complications
- (2016) Scot H. Simpson et al. ANNALS OF PHARMACOTHERAPY
- Efficacy and Tolerability of Exenatide Once Weekly Over 6 Years in Patients with Type 2 Diabetes: An Uncontrolled Open-Label Extension of the DURATION-1 Study
- (2016) Robert R. Henry et al. Diabetes Technology & Therapeutics
- Perceptions and experiences of taking oral medications for the treatment of Type 2 diabetes mellitus: a systematic review and meta-synthesis of qualitative studies
- (2016) J. McSharry et al. DIABETIC MEDICINE
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM –2016 EXECUTIVE SUMMARY
- (2016) Alan J. Garber et al. Endocrine Practice
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
- (2016) LANCET
- Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan
- (2016) Heather Gelhorn et al. Patient Preference and Adherence
- Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database
- (2016) Maureen Lage et al. Patient Preference and Adherence
- Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
- (2016) William Polonsky et al. Patient Preference and Adherence
- Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study
- (2016) Manuj Sharma et al. BMJ Open
- A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany
- (2016) Christine Poulos et al. Therapeutic Advances in Neurological Disorders
- Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
- (2016) Karel Kostev et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
- (2016) William Saunders et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study
- (2015) Erin K. Buysman et al. ADVANCES IN THERAPY
- Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany - a retrospective cohort and case control study in claims data of a large statutory health insurance
- (2015) Michael W. J. Boehme et al. BMC PUBLIC HEALTH
- Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients
- (2015) Ronan T. Grimes et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes
- (2015) A. Brett Hauber et al. CURRENT MEDICAL RESEARCH AND OPINION
- GLP-1 Receptor Agonists
- (2015) Curtis Triplitt et al. DIABETES EDUCATOR
- Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists
- (2015) Sten Madsbad DIABETES OBESITY & METABOLISM
- Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK
- (2015) Heather Gelhorn et al. Patient Preference and Adherence
- A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus
- (2015) A. Brett Hauber et al. Diabetes Therapy
- A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus
- (2015) A. Brett Hauber et al. Diabetes Therapy
- Retrospective Study of Adherence to Glucagon-like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes Mellitus in the United States
- (2014) Stephen S. Johnston et al. ADVANCES IN THERAPY
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging Agents
- (2014) Jennifer M. Trujillo et al. PHARMACOTHERAPY
- Prevalence and Incidence of Diabetes in Stockholm County 1990-2010
- (2014) Tomas Andersson et al. PLoS One
- The association between the measurement of adherence to anti-diabetes medicine and the HbA1c
- (2014) Sheila A. Doggrell et al. International Journal of Clinical Pharmacy
- GLP-1 receptor agonists: a review of head-to-head clinical studies
- (2014) Jennifer M. Trujillo et al. Therapeutic Advances in Endocrinology and Metabolism
- Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials
- (2013) Faramarz Ismail-Beigi et al. ANNALS OF INTERNAL MEDICINE
- Predictors of medication adherence in patients with type 2 diabetes mellitus
- (2013) Suellen M. Curkendall et al. CURRENT MEDICAL RESEARCH AND OPINION
- Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: Patient preferences
- (2013) A.F. Mohamed et al. DIABETES & METABOLISM
- Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK
- (2013) H. L. Gelhorn et al. DIABETES OBESITY & METABOLISM
- Global estimates of diabetes prevalence for 2013 and projections for 2035
- (2013) L. Guariguata et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
- (2013) F. Reed Johnson et al. VALUE IN HEALTH
- A discrete choice experiment to determine patient preferences for injection devices in multiple sclerosis
- (2013) S. L. Shingler et al. JOURNAL OF MEDICAL ECONOMICS
- Adherence to Therapies in Patients with Type 2 Diabetes
- (2013) Luis-Emilio García-Pérez et al. Diabetes Therapy
- Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis
- (2012) C. F. Deacon et al. DIABETES OBESITY & METABOLISM
- A network meta-analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo
- (2012) D. A. Scott et al. DIABETES OBESITY & METABOLISM
- A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
- (2011) Carl Asche et al. CLINICAL THERAPEUTICS
- Patient preferences for diabetes management among people with type 2 diabetes in Denmark – a discrete choice experiment
- (2011) Mette Bøgelund et al. CURRENT MEDICAL RESEARCH AND OPINION
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
- (2011) Goodarz Danaei et al. LANCET
- Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
- (2011) John F.P. Bridges et al. VALUE IN HEALTH
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients with Type 2 Diabetes
- (2009) Kazuya IWAMOTO et al. ENDOCRINE JOURNAL
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
- (2008) Daniel J Drucker et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now